Skip to main content
. 2011 Nov;55(11):5238–5242. doi: 10.1128/AAC.05033-11

Table 2.

Pharmacokinetic parameters of cefazolin in plasma (total and unbound) and ISF of subcutaneous adipose tissue

Pharmacokinetic parametera Median value (IQR)
Total plasma Unbound plasma Unbound ISF
Cmax (mg/liter) 404 (289–458) 25.7 (21.6–27.6) 23.7 (17.2–27.1)
Tmax (h) 0.08 (0.08–0.09) 0.08 (0.08–0.09) 2.0 (1.5–3.0)
Cmin (mg/liter) 35.7 (30.4–54.3) 5.7 (5.4–8.1) 6.7 (6.0–6.9)
t1/2 (h) 2.7 (2.4–4.1)
AUMC0-last (mg-h/liter) 53,486 (39,116–72,613) 11,444 (6,650–16,165) 8,675 (7,530–11,942)
AUMC0-∞ (mg-h/liter) 178,899 (103,300–392,810) 535,767 (304,118–641,091) 1,484,890 (485,872–2,255,884)
AUC0-last (mg-h/liter) 452 (420–542) 77.6 (59.0–82.4) 65.6 (51.7–83.5)
AUC0-∞ (mg-h/liter) 670 (518–1,113) 382 (295–420) 2,044 (994–3,857)
MRT (h) 259 (210–347) 1,402 (1,030–1,525) 147 (125–178)
kel (h) 0.26 (0.17–0.28) 0.04 (0.04–0.06) 0.22 (0.18–0.32)
CLtotal (liters/h) 3.01 (1.73–3.94)
Vz (liters) 11.6 (10.2–14.1) 119.3 (115.2–123.3)
Vz (liters/kg) 0.14 (0.11–0.15) 1.31 (1.25–1.40)
fAUCISF tissue /AUCplasmab 0.15 (0.12–0.19)
fAUCISF tissue /fAUCplasmab 0.85 (0.78–1.06)
a

Cmax, observed maximum concentration; Tmax, time that Cmax was observed; Cmin, observed minimum concentration; t1/2, elimination half-life; AUMC0-last, area under the moment curve from 0 h to the last measurement at the completion of surgery; AUMC0-∞, area under the moment curve from 0 h to infinity; AUC0-last, area under the concentration-time curve from 0 h to the last measurement at the completion of surgery; AUC0-∞, area under the concentration-time curve from 0 h to infinity; MRT, mean residence time; kel, elimination rate constant; CLtotal, total clearance; Vz, apparent volume of distribution during terminal phase; fAUCISF tissue, unbound AUC in interstitial fluid of subcutaneous tissue; AUCplasma, AUC in plasma, obtained using total concentrations; fAUCplasma, AUC in plasma, obtained using unbound concentrations.

b

Calculated using AUC0-last.